.png
)
May 1, 2020 Central Drugs Standard Control Organization (CDSCO), the Government of India Drug Regulatory Agency has extended the validity of WHO GMP/ Certificate of Pharmaceutical Product (COPP) expiring from March 2020 to August 2020 by six months from…
April 18, 2020 Central Drugs Standard Control Organization (CDSCO), the Government of India Drug Regulatory Agency has permitted the conduct of clinical trial of Convalescent Plasma In COVID-19 Patients. The trial protocol was developed and submitted by Indian Council of…
Apr 9, 2020 The Central Drugs Standard Control Organization, Government of India, has requested all State and Union Territory Drug Controllers to expedite the licensure procedure to manufacture oxygen for medical use. This is considered as a welcome move…